483 Document: Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany, Feb 17, 2023
On Feb 17, 2023, the FDA inspected Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany's Whippany site. Explore the inspectional observations.
On Feb 17, 2023, the FDA inspected Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany's Whippany site. Explore the inspectional observations.